Uncommon Neoplasms of the Biliary Tract: Radiological Findings
Overview
Authors
Affiliations
Objective: To report our cancer centre experience in the biliary tumours incidence other than cholangiocellular-carcinoma, emphasizing the radiological features.
Methods: 197 patients with biliary disease undergoing Gd-EOB-DTPA-enhanced MRI were reviewed. Four radiologists evaluated retrospectively size, structure, anatomical site and signal intensity of lesions on MRI. Enhancement-pattern during the arterial-, portal- and late-phase on ultrasound, CT and MR study was assessed as well as the enhancement pattern during the hepatobiliary-phase on MRI.
Results: 23 patients were selected. The lesion was intraductal in 5 cases, periductal in 14 and intrahepatic in 4. 16 lesions were solid, 5 uniloculated cystic and 2 complex cystic. In five patients the lesion was simple cyst, with a signal intensity in T weighted (T1W) and T weighted (T2W) similar to the gallbladder. In two patients with complex cystic lesion, the solid component was heterogeneously hypointense in T W, hyperintense in T W with a restricted diffusion. The solid component showed heterogeneous contrast-enhancement on CT, MR and ultrasound. The tumour was intrahepatic in two patients, with signal hypointense in T W and hyperintense in T W. Diffusion was restricted. The lesions showed heterogeneous contrast-enhancement. The periductal lesions were hypointense in T W, hyperintense in T W with restricted diffusion. The lesion showed progressive contrast-enhancement. Peribiliary melanoma was hyperintense in T W, hyperintense in T W with restricted diffusion and progressively contrast-enhanced.
Conclusion: Biliary tumours can have a wide spectrum of radiologic appearances and consequently represent a diagnostic challenge for the radiologist. Advances in knowledge: MRI is the technique of choice in diagnosing biliary tumours, including rare (non-CCC) tumours.
de Sio I, DOnofrio M, Mirk P, Bertolotto M, Priadko K, Schiavone C J Ultrasound. 2023; 26(3):725-731.
PMID: 37147558 PMC: 10469113. DOI: 10.1007/s40477-023-00788-2.
Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.
Granata V, Fusco R, De Muzio F, Cutolo C, Grassi F, Brunese M Biology (Basel). 2023; 12(2).
PMID: 36829492 PMC: 9952965. DOI: 10.3390/biology12020213.
A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.
De Muzio F, Grassi F, DellAversana F, Fusco R, Danti G, Flammia F Diagnostics (Basel). 2022; 12(7).
PMID: 35885561 PMC: 9319674. DOI: 10.3390/diagnostics12071655.
A case of hepatic intraductal papillary neoplasm of the bile duct.
Mukaida E, Tamura A, Nishiya M, Katoh K, Sugai T, Yoshioka K BJR Case Rep. 2022; 8(1):20210172.
PMID: 35136649 PMC: 8803234. DOI: 10.1259/bjrcr.20210172.
Radiological assessment of secondary biliary tree lesions: an update.
Granata V, Fusco R, Setola S, Avallone A, Palaia R, Grassi R J Int Med Res. 2020; 48(6):300060519850398.
PMID: 32597280 PMC: 7432986. DOI: 10.1177/0300060519850398.